关注
Nachammai KT
Nachammai KT
其他姓名Nachammai Kathiresan
在 alagappauniversity.ac.in 的电子邮件经过验证
标题
引用次数
引用次数
年份
Exploration of bioinformatics on microbial fuel cell technology: trends, challenges, and future prospects
KT Nachammai, S Ramachandran, C Nagarajan, L Kulanthaivel, ...
Journal of Chemistry 2023 (1), 6902054, 2023
62023
Diabetes and other comorbidities: Microvascular and macrovascular diseases diabetes and cancer
V Nithya, P Sangavi, R Srinithi, KT Nachammai, S Gowtham Kumar, ...
Advances in diabetes research and management, 21-39, 2023
52023
Targeting potential receptor molecules in non-small cell lung cancer (NSCLC) using in silico approaches
C Kirubhanand, J Merciline Leonora, S Anitha, R Sangeetha, ...
Frontiers in Molecular Biosciences 10, 1124563, 2023
52023
Perspective of algae materials 2.0
R Srinithi, P Sangavi, KT Nachammai, SG Kumar, K Langeswaran
Algae Materials, 383-397, 2023
32023
Antioxidant, Anti‐Inflammatory, and Anticarcinogenic Efficacy of an Ayurvedic Formulation: Amritotharanam Kashyam
LS Raman, A Shanmuganathan, S Chandrashekar, P Kaliyaperumal, ...
Advances in Pharmacological and Pharmaceutical Sciences 2023 (1), 3387261, 2023
22023
Proteomics and genomics insights on malignant osteosarcoma.
N Kathiresan, C Selvaraj, S Pandian, GK Subbaraj, AS Alothaim, SZ Safi, ...
Advances in Protein Chemistry and Structural Biology 138, 275-300, 2023
12023
Unraveling the Interaction Mechanism of the Compounds From Cladophora sp to Recognize Prospective Larvicidal and Bactericidal Activities: In vitro and In Silico Approaches
KT Nachammai, S Amaradeepa, S Raageshwari, AV Swathilakshmi, ...
Molecular Biotechnology, 1-21, 2023
12023
Next-Generation Sequencing to Study the DNA Interaction
N Kathiresan, S Ramachandran, L Kulanthaivel
Reverse Engineering of Regulatory Networks, 249-264, 2023
2023
Exploration and Validation of Lead Molecules against Yellow Fever Through High Throughput Virtual Screening and Molecular Dynamics Simulation
KCLK Nachammai Kathiresan, Sangavi Pandi, Thameema Parveen Sahul, Gowtham ...
Letters in Drug Design & Discovery 21 (8), 1417 - 1428, 2023
2023
Phospholipase A2 and hepatocellular carcinoma progression
KT Nachammai, R Srinithi, P Sangavi, R Sangeetha, SG Kumar, ...
Phospholipases in Physiology and Pathology, 219-237, 2023
2023
Therapeutic Approaches and Models in Retinoblastoma
GK Subbaraj, K Langeswaran, G Priyanka, G Ashok, M Karthikeyan, ...
Handbook of Animal Models and its Uses in Cancer Research, 1-10, 2022
2022
Discovery of Potential Inhibitors for SFRP3: Ligand-Based 3D Pharmacophore, Virtual Screening, Molecular Docking, and Dynamics Studies
S Infant Deepthi, P Sangavi, G Priyanka, C Kirubhanand, KT Nachammai
系统目前无法执行此操作,请稍后再试。
文章 1–12